Methoden vergelijken

	Dubbelblind AB-ontwerp	ABA-ontwerp
Vakgebied	Experimenteel ontwerp	Experimenteel ontwerp
Familie	Process / pipeline	Process / pipeline
Jaar van ontstaan	1960s (AB design); double-blinding integration in single-case clinical research from the 1980s–1990s	1968
Grondlegger	Derived from the AB single-subject design tradition (Sidman 1960; Baer, Wolf, & Risley 1968) combined with double-blinding conventions from clinical trial methodology	Montrose Wolf, Donald Baer, Todd Risley (applied behavior analysis tradition)
Type	Single-subject experimental design with double-blinding	Single-subject experimental design
Oorspronkelijke bron	Kazdin, A. E. (1982). Single-Case Research Designs: Methods for Clinical and Applied Settings. Oxford University Press. ISBN: 978-0195030440	Baer, D. M., Wolf, M. M., & Risley, T. R. (1968). Some current dimensions of applied behavior analysis. Journal of Applied Behavior Analysis, 1(1), 91–97.
Aliassen	blinded AB design, double-blind single-case AB, masked AB design, double-blind baseline-intervention design	reversal design, withdrawal design, ABA withdrawal design
Verwant	5	4
Samenvatting	The double-blind AB design is a single-subject experimental approach that sequences a baseline phase (A) and an intervention phase (B) while concealing phase allocation from both the participant and the outcome assessor. It merges the idiographic focus of single-case methodology with the bias-control mechanism of double-blinding, making it especially useful in clinical rehabilitation, pain research, and behavioral medicine when objective measurement of an individual's response to treatment is the primary goal.	The ABA design is a single-subject experimental design that demonstrates experimental control through three sequential phases: a baseline phase (A1), an intervention phase (B), and a return-to-baseline withdrawal phase (A2). By removing the intervention in the final phase and observing whether behavior reverts toward baseline levels, researchers establish a functional relationship between the treatment and the target behavior for an individual participant.